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Creating a more robust 
5-hydroxymethylfurfural oxidase by combining 
computational predictions with a novel 
effective library design
Caterina Martin, Amaury Ovalle Maqueo, Hein J. Wijma and Marco W. Fraaije*
Abstract 
Background: HMF oxidase (HMFO) from Methylovorus sp. is a recently characterized flavoprotein oxidase. HMFO is 
a remarkable enzyme as it is able to oxidize 5-hydroxymethylfurfural (HMF) into 2,5-furandicarboxylic acid (FDCA): a 
catalytic cascade of three oxidation steps. Because HMF can be formed from fructose or other sugars and FDCA is a 
polymer building block, this enzyme has gained interest as an industrially relevant biocatalyst.
Results: To increase the robustness of HMFO, a requirement for biotechnological applications, we decided to 
enhance its thermostability using the recently developed FRESCO method: a computational approach to identify 
thermostabilizing mutations in a protein structure. To make this approach even more effective, we now developed a 
new and facile gene shuffling approach to rapidly combine stabilizing mutations in a one-pot reaction. This allowed 
the identification of the optimal combination of seven beneficial mutations. The created thermostable HMFO mutant 
was further studied as a biocatalyst for the production of FDCA from HMF and was shown to perform significantly 
better than the original HMFO.
Conclusions: The described new gene shuffling approach quickly discriminates stable and active multi-site variants. 
This makes it a very useful addition to FRESCO. The resulting thermostable HMFO variant tolerates the presence of 
cosolvents and also remained thermotolerant after introduction of additional mutations aimed at improving the cata-
lytic activity. Due to its stability and catalytic efficiency, the final HMFO variant appears to be a promising candidate for 
industrial scale production of FDCA from HMF.
Keywords: Enzyme engineering, Carbohydrate, Poly(ethylene-furandicarboxylate) PEF, Computational library, Golden 
Gate gene shuffling
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Background
The solution to overcome the increasing demand for 
polymers, while fossil oil resources are rapidly deplet-
ing, could be the use of biomass as a renewable starting 
material [1]. A promising alternative to the petroleum-
based poly(ethylene-terephthalate) (PET) polymer is 
poly(ethylene-furandicarboxylate) (PEF). Thanks to 
its similar characteristics, PEF has attracted attention, 
because it is a bio-based polymer obtained from furan-
2,5-dicarboxylic acid (FDCA) and this monomer can be 
synthesized from the most abundant renewable material: 
carbohydrates [2, 3]. For this reason, FDCA production 
has gained a lot of interest and different methods have 
been developed to convert carbohydrates or carbohy-
drate derived products (such as HMF) into FDCA [4]. 
Chemical methods to obtain FDCA from HMF by homo-
geneous or supported metal catalysts typically present 
several disadvantages: high costs, low yields, byproducts, 
and the requirement of organic solvents which are not 
environmentally sustainable [5, 6]. Several biocatalytic 
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routes from HMF to FDCA have recently been described 
[7–9]. Among these approaches, only one was shown 
to be dependent on merely one biocatalyst, HMF oxi-
dase (HMFO), a highly attractive feature. We identified 
HMFO in the predicted proteome of Methylovorus sp. 
strain MP688 [8]. The oxidase contains a flavin adenine 
dinucleotide (FAD) cofactor as prosthetic group and 
only requires molecular oxygen as electron acceptor to 
catalyze various oxidation reactions which include alco-
hol and thiol oxidations [8, 10]. HMFO was shown to be 
capable to convert HMF into FDCA in a three-step reac-
tion (Scheme 1) [8, 10]. To develop HMFO into an indus-
trially applicable biocatalyst, its catalytic and stability 
properties have to be improved. While the enzyme is effi-
cient in catalyzing the first step in the catalytic cascade, 
it is rather inefficient in the last step. Furthermore, the 
enzyme displays only a modest stability. Upon elucidating 
the crystal structure of HMFO, we successfully identified 
mutations that improve its performance in oxidation of 
the hydrated form of 5-formyl-2-furancarboxylic acid 
(FFA) to FDCA, the last step in the catalytic cascade [11]. 
The mutant V367R-W466F HMFO was found to be the 
best variant for FDCA production with a kcat/Km value 
for FFA conversion > 1000-fold higher than for the wild-
type enzyme [11]. Yet, as often observed when engineer-
ing enzyme activity, the higher catalytic performance was 
at the expense of enzyme thermostability.
Since HMFO has the potential to become an impor-
tant biocatalytic tool, development of a robust variant 
is essential. An enzyme with a higher thermostability 
will be more suitable for use under harsh reaction con-
ditions such as elevated temperatures and the presence 
of organic cosolvents [12]. Moreover, a stable enzyme 
is the ideal template for further enzyme engineering 
efforts aimed to improve or change its catalytic proper-
ties [13]. Several methods have been designed to enhance 
the (thermo)stability of enzymes [14]. Completely ran-
dom approaches like directed evolution can be effective 
but are time-consuming and require high-throughput 
screening methods [15].
Rational design of stabilizing mutations is still chal-
lenging due to the fact that it is too complicated to accu-
rately explain the effects of a mutation in terms of ΔΔH 
and ΔΔS [16]. Yet, state-of-the-art computational meth-
ods have evolved to such a level that they have predictive 
value in selecting putative thermostabilizing mutations. 
This can be used as input for the design of relatively small 
mutant libraries for screening in  vitro [17]. We have 
recently developed a framework for rapid enzyme stabi-
lization by computational libraries (FRESCO) which is a 
computationally assisted method that includes predict-
ing a large number of independent stabilizing mutations 
that are in silico screened to define a relatively small set 
of mutations that need to be tested experimentally [18, 
19]. This approach has demonstrated its validity with dif-
ferent enzymes, leading to high Tmapp improvements of 
up to 35 °C [18, 20–22]. The initial steps of the FRESCO 
strategy consist of computational and visual selections 
based on free energy predictions and molecular dynamic 
(MD) simulations of single point mutations. This is fol-
lowed by an in vitro phase to identify variants with sig-
nificantly improved stability, and finally, the combination 
of the selected mutations should result in a highly stable 
enzyme variant. FRESCO is an attractive approach when 
dealing with a protein for which the crystal structure has 
been determined and, therefore, HMFO is a suitable can-
didate. The aim of this work was to obtain a stable HMFO 




The in silico phase of the FRESCO strategy was neces-
sary to create an enriched library of single point mutants 
of HMFO. The crystal structure of the reduced form of 
the enzyme (PDB:4UDQ) was selected as model as it 
was solved at a better resolution (1.6 Å) than the oxi-
dized enzyme [11]. Using this structure, all possible 
point mutations were modeled (excluding residues that 
are within 5 Å from the FAD cofactor) and their respec-
tive values in free energy of folding were compared with 
that of the wild-type enzyme (∆∆GFold). By omitting 
the residues that are close to the active site, the risk of 
creating a mutant with lower or no activity is limited. 
The first in silico step consisted of a selection based on 
free energy prediction: single mutants with a predicted 
∆∆GFold higher than −  5  kJ  mol−1 were discarded. This 
decreased the number of variants to screen from 9044 to 
744. The dynamic disulfide discovery (DDD) algorithm 
was not included in this FRESCO approach, because 
Scheme 1 Oxidation reaction of 5-hydroxymethylfurfural (HMF) to 2,5-furandicarboxylic acid (FDCA) by HMFO
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disulfide bonds may complicate protein expression [22]. 
The MD simulations of the 744 variants were visually 
inspected comparing the modeled structure of the wild-
type with the mutant ones. The goal was to select vari-
ants with putative improvements in their thermostability 
profile. The screening was based on avoiding features 
that are normally found to cause a decrease in stability 
such as an increased flexibility (backbone and sidechain), 
an increase in hydrophobic surface exposure and dimin-
ished hydrogen-bonding interactions [23]. Those 140 
mutants that scored well in the free energy of folding 
and did not show such aberrant structural features upon 
MD simulation and visual inspection were selected to be 
experimentally tested for thermostability.
Screening of single mutants
Using PCR, all 140 mutations were introduced in the 
HMFO expression plasmid. The 140 mutant proteins and 
wild-type HMFO were produced in 96-well plates, which 
allowed efficient testing of all variants. To establish the 
effect of each mutation on stability, the apparent melting 
temperature (Tmapp) was determined for each variant using 
the ThermoFAD assay [24]. The latter method reports on 
the temperature at which the flavin cofactor is released 
from the protein, thereby becoming more fluorescent, 
because flavin fluorescence is typically quenched when it 
is bound in a protein. This provides a good estimate of 
the thermostability of the studied flavoprotein as cofactor 
release is the result of protein unfolding. Because HMFO 
is well expressed, we did not only determine the Tmapp 
value for each variant after enzyme purification, but the 
Tmapp was also measured using cell extracts. This revealed 
that the stability of the variants could also be measured 
in cell extracts as the Tmapp values obtained with cell-free 
extracts were quite consistent compared with the purified 
enzymes. It demonstrates that the ThermoFAD method 
can be a very powerful approach to efficiently screen 
a large set of flavoprotein variants without the need for 
enzyme purification. Importantly, the ThermoFAD meas-
urements revealed 17 mutations that led to a significant 
positive ΔTmapp in comparison with the wild-type enzyme 
(Fig. 1) (Additional file 1: Table S1).
Golden Gate gene shuffling
As next step in the FRESCO method, the best combina-
tion of beneficial mutations needs to be identified. The 
addition of several single mutations does not necessar-
ily lead to a more thermostable variant, because benefi-
cial single mutations may not be compatible. So far, the 
strategy to combine the mutations was based on a good 
analysis of the ΔTmapp together with the mutation position 
and its predicted effect. Yet, such an approach is time-
consuming, since the mutations need to be combined in 
a step-wise fashion, one by one or in groups and tested 
at each step [18, 20–22]. We set out to develop a more 
effective method to quickly identify the best combina-
tion of mutations that results in a stable and active vari-
ant. For this, we aimed at randomly combining mutations 
through a gene shuffling approach. Various gene shuf-
fling methods have been developed in the field of pro-
tein engineering, often with the focus to merge certain 
wanted properties of two or more distinct proteins into 
one [25, 26]. We developed a controlled approach that 
can be applied in cases when it is desired to test all differ-
ent combinations of several specific gene fragments (with 
predefined mutations). In our method, we take advantage 
of the fact that gene (fragment) synthesis has become 
relatively cheap [27]. For the gene shuffling library, we 
chose the eight mutations which resulted in the highest 
Tmapp values: I73V, H74Y, Q187E, G356H, V367L, T414K, 
A419Y, and A435E. To assess if the catalytic properties 
of the corresponding mutant enzymes were un-affected, 
we measured HMFO activity towards vanillyl alcohol [8]. 
The benefit of using this substrate is that it allows direct 
detection of product formation as the formed vanil-
lin displays light absorbance at 340 nm. Gratifyingly, all 
mutants showed similar activity when compared with 
the wild-type enzyme (Additional file 2: Table S2). Before 
performing gene shuffling, the mutations I73V and H74Y, 
being neighboring residues, were combined to verify 
whether they display an additive effect. This was found to 
be the case as the double mutant presents a Tmapp that is 
6  °C higher when compared with the wild-type enzyme 
(the single mutations displayed 3–4  °C higher Tmapp val-
ues, Fig.  1). This double mutation was included in the 
gene shuffling approach instead of the two individual 
Fig. 1 ΔTm
app values of 17 selected mutants. The values correspond to 
an increase in Tm
app when compared with WT HMFO (Tm
app = 48.5 °C)
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mutations, reducing the number of mutation sites to 7. 
The aim of the gene shuffling approach was to create a 
library of all the possible combinations (128) of the 
selected 7 sites and subsequently test them for thermo-
stability and activity towards HMF. The gene shuffling 
protocol described in this work is based on the Golden 
Gate cloning system [28]. Previously, other approaches 
used type IIs restriction enzymes to combine gene frag-
ments or plasmid modules; these methods involve clon-
ing of each module flanked by BsaI sites in individual 
vectors, or add type IIs restriction enzyme sites by sepa-
rate PCRs for each module [29, 30]. The Golden Gate 
gene shuffling which we developed for the FRESCO 
strategy is a one-pot reaction that involves only three 
designed vectors and a single restriction–ligation reac-
tion (Fig. 2).
The first step was the design of two synthetic genes, one 
wild-type version and one with the selected 7 mutations; 
each containing 8 BsaI restriction sites that flank the 7 
gene modules that contain the target mutation sites. The 
positions of the modules were defined identically for the 
two versions and were designed, such that all the desired 
mutation sites could be introduced in separate modules 
and that the four-nucleotide overhangs for the ligation 
were unique and not palindromic. The innovation of 
this method is in the design of the BsaI restriction sites. 
Each module is flanked by two BsaI sites: between two 
modules there are two mirrored BsaI sites and the four 
overhang nucleotides at the end of each module are repli-
cated at the beginning of the following module to allow a 
scarless ligation. By performing the one-pot Golden Gate 
cloning reaction on the mixture of the two donor vec-
tors, containing the two synthetic genes, and the accep-
tor pBAD vector, all possible combinations of the 7 gene 
fragments are created in the pBAD-based expression vec-
tor. The Golden Gate gene shuffling library was analyzed 
by sequencing to confirm the heterogeneity and accuracy 
of the shuffling of gene fragments. The results showed 
that 97% of the colonies contained the correct restriction 
pattern and the shuffling efficiency was 65%. This indi-
cates that per 100 clones, 65 contain non-redundant ran-
domly shuffled sequences.
Shuffled library screening
The gene shuffling library was tested to establish Tmapp of 
the variants and also their activity towards HMF. To be 
Fig. 2 Design of the synthetic genes for Golden Gate gene shuffling. a BsaI recognition sites between two modules are flanked and mirrored. The 
four nucleotides at the end of one fragment are replicated at the beginning of the next one to avoid nucleotide loss after the ligation. b Donor 
vectors have the same fragment arrangement. The wild-type fragments are represented in green, while the fragments in orange have one mutation 
site each. The dotted sections (pUK57 backbone and BsaI sites) are lost after the ligation. The shuffled library consists of pBAD SUMO-HMFO vectors 
with a random combination and correct order of the 7 gene modules (with mutations)
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sure of screening all the possible combinations, the tested 
library size was 3.5-fold the number of possible combi-
nations. The results of the ThermoFAD analysis showed 
that the 8xHMFO (I73V, H74Y, Q187E, G356H, V367L, 
T414K, A419Y, and A435E) was the most thermosta-
ble variant with an improvement of 13  °C compared 
with the WT (Tmapp =  48.5  °C). Yet, an alignment of the 
best 9 multi-site mutants that presented an higher Tmapp 
together with a preserved ability to oxidize HMF demon-
strated that the mutation Q187E had a negative effect on 
the activity (Additional file  3: Table  S3). This shows the 
advantage of using a gene shuffling approach to evaluate 
the best thermostable and active mutant. Therefore, the 
best multiple mutant was considered to be the 7xHMFO 
mutant (I73V, H74Y, G356H, V367L, T414K, A419Y, and 
A435E) with a Tmapp of 60.5 °C and kcat and Km values com-
parable with the wild-type enzyme (Table 1) [8].
To further investigate the thermostable properties of 
the 7xHMFO mutant, its stability over time at 40 °C was 
investigated. The 7xHMFO variant presented a remark-
able stability compared to the wild-type enzyme. While 
wild-type HMFO completely lost its activity after 2 days, 
the thermostable variant retained 50% of its activity even 
after 10 days of incubation at 40 °C (Additional file 5: Fig-
ure S2). Since HMFO is able to oxidize many different 
substrates, including compounds that are poorly solu-
ble in water, we investigated the stability in the presence 
of different cosolvents. The 7xHMFO showed a much 
higher tolerance towards four commonly used cosolvents 
when compared with the wild-type enzyme (Fig. 3). The 
7xHMFO mutant with its higher thermostability, solvent-
tolerance, and preserved catalytic activity represents an 
excellent template for further engineering.
Engineering of thermostable HMFO variant for FDCA 
production
To further tune the 7xHMFO variant towards conver-
sion of HMF into FDCA, we introduced two muta-
tions (V367R and W466F) in the active site that have 
been shown to be beneficial for FDCA production from 
HMF [11]. Since V367 had already been mutated in the 
7xHMFO variant (V367L), we included in the analy-
sis also another 8xHMFO variant with only the W466F 
mutation. The variants were tested, and as expected, the 
additional mutation(s) introduced into the 7xHMFO 
decreased the Tmapp. Yet, the stability remained signifi-
cantly higher than the wild-type enzyme (Table 2).
To determine whether the thermostable variants are 
more potent biocatalysts than the previously described 
wild-type and/or V367R W466F HMFO mutant, we tested 
the conversion rates using HMF as a substrate. The best 
thermostable variant for FDCA production turned out to 
be the newly engineered 8BxHMFO. The data revealed 
that this HMFO variant performs significantly better than 
the wild-type and the double mutant (Fig. 4) (Additional 
file 6: Table S4). At 25 °C, an almost full conversion in 24 h 
could be achieved, while the conversion with the double 
mutant and the wild-type enzyme remained below 50 
and 5%, respectively. Since all the generated thermosta-
ble HMFO variants exhibit Tmapp values higher than 50 °C, 
we decided to perform conversions also at 40 °C. At this 
temperature, only the 8BxHMFO mutant performed well 
(> 95% conversion in only 9 h) (Additional file 7: Table S5). 
Table 1 Steady-state parameters of the different HMFO 
variants on HMF
Kinetic parameters were determined by measuring  H2O2 formation in a coupled 
assay using HMF as substrate (Additional file 4: Figure S1)
HMFO kcat  (s
−1) Km (mM) kcat/Km  (s
−1 mM−1)
WT 13.7 1.52 9.03
7xHMFO 11.8 0.63 18.7
Fig. 3 Tm
app in the absence or presence of 15% 1,4-dioxane, methanol, 
dimethyl sulfoxide, or ethanol. Kpi is the control in 50 mM phosphate 
buffer, pH 8.0
Table 2 Tm
app values of HMFO variants
Tm
app values of HMFO variants (30 μM) obtained by ThermoFAD in phosphate 
buffer 50 mM pH 8.0
a The 7xHMFO variant includes the mutations: I73V, H74Y, G356H, V367L, T414K, 
A419Y, and A435E
b The 8AxHMFO variant includes the mutations: I73V, H74Y, G356H, V367L, 
T414K, A419Y, A435E, and W466F
c The 8BxHMFO variant includes the mutations: I73V, H74Y, G356H, V367R, 
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The kcat/Km of the 8BxHMFO is 0.1 s−1 mM−1 which com-
pared to the reported kcat/Km value of the double mutant 
is relatively low (2.2  s−1  mM−1) (Additional file  8: Fig-
ure S3) [11]. This indicates that the higher conversion 
is largely due to an improved operational stability. The 
results indicate that this engineered version of HMFO can 
be used for longer time and can lead in this way to higher 
amounts of FDCA.
Conclusions
In this work, we further developed the FRESCO protocol 
by developing a novel and efficient approach for combin-
ing individual stabilizing mutations. The Golden Gate 
gene shuffling described in this study was fundamental 
to rapidly identify the best combination of thermosta-
bilizing mutations that led to a stable and active HMFO 
variant. The engineered 7xHMFO variant presented a 
Tmapp improvement of 12 °C compared with the wild-type 
enzyme together with an improved cosolvent tolerance. 
We could also demonstrate that this thermostable variant 
of HMFO can be used as template to introduce a desta-
bilizing mutation in the active site. One of the resulting 
HMFO mutants displayed superior performance com-
pared to previously reported HMFO variants in convert-
ing HMF in a three-step one-enzyme reaction into FDCA.
Methods
Materials
All materials were acquired from Sigma-Aldrich unless 
otherwise specified.
Computational methods
The FRESCO method was employed to obtain a ther-
mostabilized variant of HMFO. Computational mod-
eling was performed using the 4UDQ X-ray structure 
of HMFO (1.6 Å resolution). To avoid mutations that 
could interfere with the active site, only residues that 
were > 5 Å away from FAD were mutated [11]. The com-
putational selection was started with calculating the 
predicted change of free folding energy (ΔΔGFold) with 
FoldX (foldx.crg.es) and Rosetta-ddg (http://www.roset 
tacom mons.org) [18, 19, 31]. For Rosetta, the so-called 
row-3 protocol (described by Kellogg et  al. in row 3 of 
their table  1) was invoked using the following options: 
-ddg::weight_file soft_rep_design -ddg::iterations 50 
-ddg::local_opt_only true -ddg::min_cst false -ddg::mean 
true -ddg::min false -ddg::sc_min_only false -ddg::ramp_
repulsive false -ddg::opt_radius 8.0 [32]. For FoldX, the 
used options were --command=BuildModel --number-
OfRuns=5. The single point mutations with a predicted 
ΔΔGFold < − 5 kJ mol−1 were subsequently submitted to 
MD simulations under Yasara as previously described [18, 
19]. The averaged structures from the MD trajectories 
were visually inspected comparing the variant simulations 
with the wild-type HMFO while examining backbone and 
sidechain flexibility, hydrogen bonds, and hydrophobic 
exposure. This last in silico step is to further reduce the 
number of potentially thermostable variants to experi-
mentally screen. All FRESCO specific scripts and code are 
available at https ://www.rug.nl/staff /h.j.wijma .
Genetic engineering
For all the experiments, the His6x-SUMO-HMFO fusion 
has been used as it has been demonstrated before that the 
SUMO protein fused at the N-terminus does not affect the 
activity nor the thermostability of HMFO [8]. The gene 
single point variants, the double mutant I73V H74Y, the 
8AxHMFO, and the 8BxHMFO were obtained from pET 
SUMO-HMFO or pBAD SUMO-7xHMFO by whole-plas-
mid PCR with PfuUltra II Hotstart PCR Master Mix (Agi-
lent). Template DNA was cleaved with DpnI (New England 
Biolabs) for at least 2 h at 37 °C. Escherichia coli NEB 10β 
(New England Biolabs) chemically competent cells were 
transformed (heat shock at 41 °C for 45 s) and cells plated 
on 50 μg mL−1 kanamycin or 100 μg mL−1 ampicillin LB 
agar plates. All mutations were confirmed by sequencing.
Golden Gate gene shuffling
The eightfold mutants were obtained using a gene shuf-
fling approach. For this, we designed two synthetic gene 
versions of hmfo: one with 7 modules each containing 
Fig. 4 Production of FDCA from HMF at 25 °C by HMFO variants. 
WT (filled triangle), V367R W466F HMFO (filled circle), 8BxHMFO 
(I73V-H74Y, G356H, V367R, T414K, A419Y, A435E, and W466F) (filled 
square). Conversions were performed in duplicates in phosphate 
buffer 50 mM pH 8.0, HMFO 2.0 μM, HMF 5.0 mM, 25 °C
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one mutated region (the first module containing 2 muta-
tions, and the 8 mutations are: I73V-H74Y, Q187E, 
G356H, V367L, T414K, A419Y, A435E) and the other 
synthetic gene with the same modules arrangement but 
without mutations, corresponding to the wild-type DNA 
sequence. Each module had been designed to be flanked 
by BsaI recognition sites: NGAG ACC at the beginning 
and GGT CTC N at the end. Moreover, at the beginning 
of each fragment, the last 4 base pairs (bp) of the previ-
ous module are repeated (or the 5′-4 bp of the overhang 
region of the acceptor plasmid in the case of the first frag-
ment and at the end of the 7th fragment are replicated 
4 bp of the 3′-ligation site of the receiving plasmid). The 
BsaI cutting sites have been chosen to be unique (at least 
3 out of 4 nucleotides in the sticky end have to be dif-
ferent) and not palindromic to avoid unwanted ligations 
(Additional file 9: Gene Sequences). The synthetic genes 
have been ordered (GenScript) cloned in two pUK57. 
A derivative of pBAD SUMO vector designed with BsaI 
cutting site 5′-TGGTngagacc and ggtctcnCTTG-3′) was 
used as receiving vector. The restriction–ligation reaction 
was set up in 20 μL volume with the components: pBAD 
SUMO 3.75  ng  μL−1, pUC57wt 2.5  ng  μL−1, pUC578x-
mutant 2.5 ng μL−1, T4 DNA ligase buffer (Promega), T4 
DNA ligase 1.5 U μL−1 (Promega), BsaI 1 U μL−1 (New 
England Biolabs); the thermocycler program was: incu-
bation at 37 °C for 5 min and at 16 °C for 10 min repeated 
50 times, followed by a final incubation at 50  °C for 
10 min (final digestion) and at 80 °C for 10 min (enzyme 
inactivation). The restriction–ligation reaction (5 μL) 
were used to transform 100 μL of chemically competent 
NEB 10β cells plated on 100 μg mL−1 ampicillin LB agar 
plates. The hmfo variants were verified first by colony 
PCR (DreamTaq Green PCR Master Mix, Thermo Fisher) 
to determine the inserts size and then by sequencing.
Large‑scale expression and purification
For HMFO expression, a culture was started by inoculat-
ing 5 mL of preculture (LB supplemented with 50 μg mL−1 
kanamycin or 100  μg  mL−1 ampicillin) in 100  mL  TB 
(Terrific Broth with the same antibiotic). In the case of 
pET constructs, protein expression was induced at  OD600 
0.5 with 1.0  mM isopropyl β-d-1-thiogalactopyranoside 
(IPTG), and with 0.02% l-arabinose in the case of the 
pBAD SUMO-HMFO construct. The latter was obtained 
by cloning the HMFO DNA sequence using NdeI and 
HindIII (NEB) in pBAD SUMO. Cells were grown over-
night at 24 °C 135 rpm and harvested at 5000g for 10 min 
at 4  °C. The cells pellet was resuspended in 10  mL of 
50 mM Tris HCl pH 8.0 with 150 mM NaCl and sonicated 
3″ on 6″ off at 70% amplitude. The enzyme was purified 
from the cell-free extract as described previously [8].
Small‑scale expression
The single point variants were expressed in E. coli 
BL21(DE3) cells with the pET SUMO-HMFO vector. 
The cultures were prepared using 600 μL of overnight 
culture (LB supplemented with 50 μg mL−1 kanamycin) 
to inoculate 5 mL TB containing 50 μg mL−1 kanamycin 
in a 24-well plate. The multi-site variants were expressed 
with the pBAD SUMO-HMFO vector in E. coli NEB 10β 
cells; the cultures were made by inoculating 200 μL of 
overnight culture (LB supplemented with 100  μg  mL−1 
ampicillin) in 800 μL of TB (100 μg mL−1 ampicillin) in 
96-well plate. The cultures were incubated at 37 °C with 
a shaking at 300 rpm and induced with 1.0 mM IPTG [in 
case of E. coli BL21(DE3) cells carrying the pET SUMO-
HMFO vector] or with 0.02% l-arabinose (E. coli NEB 
10β cells carrying the pBAD SUMO-HMFO vector) at an 
optical density at 600 nm  (OD600) of 2.0. Expression con-
tinued overnight at 24 °C with shaking at 550 rpm.
Small‑scale purification
Cells were harvested by centrifugation at 2250g for 
20 min at 4 °C. The cell-free extract was obtained after 
cell lysation: the cell pellet was solubilized in 200 μL 
lysis buffer (lysozyme 1  mg  mL−1, deoxyribonuclease I 
0.5 mg mL−1,  MgCl2 10 mM in 50 mM Tris HCl pH 8.0). 
The solubilized pellet was incubated for 30 min at 25 °C 
(shaking at 550  rpm), and then, it was frozen in liquid 
nitrogen and centrifuged at 2250g for 45  min at 4  °C. 
The soluble fraction was filtered (Whatman UNIFILTER 
96-well Microplate, GE-Healthcare) at 7g for 15 s at 4 °C 
and mixed with 100 μL of pre-equilibrated Ni-Sepharose 
resin (GE-Healthcare) for 15  min using an AcroPrep 
Advance 1 mL 96-well plate (Pall). The flow through was 
removed and the column was washed 2 times with 200 
μL of 50 mM Tris HCl pH 8.0 with 150 mM NaCl, and 
one time with the same buffer containing 5 mM imida-
zole. The protein was eluted with 100 μL of 50 mm Tris 
HCl with 150 mM NaCl containing 500 mM imidazole. 
The eluate was desalted in 50 mM phosphate buffer pH 
8.0 using PD MultiTrap G-25 plates (GE-Healthcare).
Thermostability assay
The melting temperature of HMFO cell-free extract or 
purified variants was tested by the ThermoFAD method, 
which allows to determine the unfolding temperature 
based on the release of the flavin cofactor [8, 24]. This 
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assay was performed using 20 μL of CFE or 20 μL of puri-
fied enzyme in 50  mM phosphate buffer at pH 8.0. The 
ThermoFAD was also used to determine enzyme con-
centration after the small-scale purification based on the 
dT/fluorescence value using a calibration line. The cali-
bration curve prepared with several WT concentrations 
proved that enzyme concentration does not affect the 
Tmapp.
Activity assays
All the activity assays were performed in 50  mM phos-
phate buffer pH 8.0 at 25  °C. The HMFO mutants I73V, 
H74Y, Q187E, G356H, V367L, T414K, A419Y, A435E 
were tested using enzyme activity towards vanillyl alco-
hol as reported previously [8]. The gene shuffling library 
was tested with the coupled  H2O2 detection assay: 
horseradish peroxidase (HRP) (Sigma), 0.004 U  μL−1, 
4-aminoantipyrine (0.1  mM), 3,5-dichloro-2-hydroxy-
benzenesulfonic acid (1 mM), and HMF (10 mM), meas-
uring at 515  nm (ε515 =  26  mM−1  cm−1) the formation 
of pink product due to  H2O2 production during the oxi-
dation of HMF by HMFO. This HRP coupled assay was 
also used to determine kcat, Km, and the activity after 
the incubation at 40 °C for HMFO wild type and for the 
thermostable.
Product identification
The conversion performed by HMFO WT, HMFO 
V367R-W466F, HMFO I73V-H74Y-G356H-V367L-
T414K-A419Y-A435E (7xHMFO), HMFO I73V-
H74Y-G356H-V367L-T414K-A419Y-A435E-W466F 
(8AxHMFO), HMFO I73V-H74Y-G356H-V367R-T414K-
A419Y-A435E-W466F (8BxHMFO), using 5.0  mM 
5-(hydroxymethyl)furfural as a substrate were carried out 
at 25 or 40 °C, with shaking at 1000 rpm. After the con-
version, the enzyme was inactivated at 80 °C for 10 min 
and eliminated by centrifugation. The products were 
analyzed by high-performance liquid chromatography as 
described previously [8].
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